Cargando…
Durable tracking anti-SARS-CoV-2 antibodies in cancer patients recovered from COVID-19
Cancer patients are more susceptible to SARS-CoV-2 infection and generally have higher mortality rate. Anti-SARS-CoV-2 IgG is an important consideration for the patients in this COVID-19 pandemic. Recent researches suggested the rapid decay of anti-SARS-CoV-2 antibodies in the general population, bu...
Autores principales: | Huang, Yongsheng, Yu, Jing, Li, Dan, He, Kai, Liu, Wenyang, Wang, Lin, Chen, Yeshan, Xie, Conghua, Wu, Xiaowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405618/ https://www.ncbi.nlm.nih.gov/pubmed/34462453 http://dx.doi.org/10.1038/s41598-021-96195-w |
Ejemplares similares
-
Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects
por: Huynh, Angela, et al.
Publicado: (2021) -
Investigation of Durability of SARS-CoV-2-specific IgG and IgM Antibodies in Recovered COVID-19 Patients: A Prospective Study
por: Zamani, Mohammad, et al.
Publicado: (2022) -
Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak
por: Chen, Yeshan, et al.
Publicado: (2020) -
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection
por: Tan, Yun, et al.
Publicado: (2020) -
Immune recall improves antibody durability and breadth to SARS-CoV-2 variants
por: Chen, Yuezhou, et al.
Publicado: (2022)